Novel gene markers of immunosuppressive chemicals in mouse lymph node assay

Toxicology Letters

Volumn 205, Issue 1, 2011, Pages 79-85

  Oshida, Keiyu ^a   Maeda, Akihisa ^a   Kitsukawa, Mika ^a   Suga, Sachiko ^a   Iwano, Shunsuke ^a   Miyoshi, Tomoya ^a   Miyamoto, Yohei ^a  

^a Pharmaceutical Research Laboratories   (Japan)

Author keywords

Gene expression; Gene marker; Immunosuppressive chemical; Local lymph node assay (LLNA); Mouse

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; METHOTREXATE; PREDNISOLONE; PROTEIN CBLL1; PROTEIN FMO2; PROTEIN GBP1; PROTEIN GJB1; PROTEIN KRT8; PROTEIN LIAS; PROTEIN LTF; PROTEIN MUP2; PROTEIN MUP5; PROTEIN SERINC3; PROTEIN ZFP459; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; LYMPH NODE ASSAY; MARKER GENE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ALKYLATING AGENTS; ANIMALS; ANTIMETABOLITES; BODY WEIGHT; CALCINEURIN; FEMALE; GENE EXPRESSION; GENETIC MARKERS; IMMUNOSUPPRESSIVE AGENTS; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SODIUM DODECYL SULFATE; STEROIDS;

ANIMALIA; MURINAE;

EID: 79960029920     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.05.1017     Document Type: Article

References (47)

1. Al-Kandari W., Jambunathan S., Navalgund V., Koneni R., Freer M., Parimi N., Mudhasani R., Fontes J.D. ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription. Mol. Immunol. 2007, 44:311-321.
2. Andrade-Rozental A.F., Rozental R., Hopperstad M.G., Wu J.K., Vrionis F.D., Spray D.C. Gap junctions: the "kiss of death" and the "kiss of life" Brain Res. Brain Res. Rev. 2000, 32:308-315.
3. Baken K.A., Pennings J.L., Jonker M.J., Schaap M.M., de Vries A., van Steeg H., Breit T.M., van Loveren H. Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol. Appl. Pharmacol. 2008, 226:46-59.
4. Basketter D.A., Gerberick F., Kimber I. The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermat. 2007, 57:70-75.
5. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
6. Boverhof D.R., Gollapudi B.B., Hotchkiss J.A., Osterloh-Quiroz M., Woolhiser M.R. Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA). Toxicol. Sci. 2009, 107:427-439.
7. Cockshott A., Evans P., Ryan C.A., Gerberick G.F., Betts C.J., Dearman R.J., Kimber I., Basketter D.A. The local lymph node assay in practice: a current regulatory perspective. Hum. Exp. Toxicol. 2006, 25:387-394.
8. De Jong W.H., Tentij M., Spiekstra S.W., Vandebriel R.J., Van Loveren H. Determination of the sensitising activity of the rubber contact sensitisers TMTD, ZDMC MBT and DEA in a modified local lymph node assay and the effect of sodium dodecyl sulfate pretreatment on local lymph node responses. Toxicology 2002, 176:123-134.
9. Donauer J., Rumberger B., Klein M., Faller D., Wilpert J., Sparna T., Schieren G., Rohrbach R., Dern P., Timmer J., Pisarski P., Kirste G., Walz G. Expression profiling on chronically rejected transplant kidneys. Transplantation 2003, 76:539-547.
10. Erickson L.M., Pan F., Ebbs A., Kobayashi M., Jiang H. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. Transplantation 2003, 15:582-588.
11. Figueroa A., Fujita Y., Gorospe M. Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle 2009, 8:3648-3651.
12. Fontecave M., Ollagnier-de-Choudens S., Mulliez E. Biological radical sulfur insertion reactions. Chem. Rev. 2003, 103:2149-2166.
13. Fujino M., Kitazawa Y., Kawasaki M., Funeshima N., Kimura H., Nakajima T., Saito H., Li X.K. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transpl. 2004, 10:379-391.
14. Gamsjaeger R., Liew C.K., Loughlin F.E., Crossley M., Mackay J.P. Sticky fingers: zinc-fingers as protein-recognition motifs. Trends Biochem. Sci. 2007, 32:63-70.
15. González-Chávez S.A., Arévalo-Gallegos S., Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 2009, 33:301.e1-301.e8.
16. Gutting B.W., Bouzahzah F., Kong P.L., Updyke L.W., Amacher D.E., Craft J. Oxazolone and diclofenac-induced popliteal lymph node assay reactions are attenuated in mice orally pretreated with the respective compound: potential role for the induction of regulatory mechanisms following enteric administration. Toxicol. Appl. Pharmacol. 2003, 189:120-133.
17. Homey B., Schuppe H.C., Assmann T., Vohr H.W., Lauerma A.I., Ruzicka T., Lehmann P. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. Eur. J. Pharmacol. 1997, 325:199-207.
18. Jeon B.N., Choi W.I., Yu M.Y., Yoon A.R., Kim M.H., Yun C.O., Hur M.W. ZBTB2, a novel master regulator of the p53 pathway. J. Biol. Chem. 2009, 284:17935-17946.
19. Karaji A.G. Application of popliteal lymph node assay to evaluate tolerogenic effect of donor leukocyte infusion. Transpl. Immunol. 2006, 16:20-24.
20. Kimber I., Basketter D.A. The murine local lymph node assay: a commentary on collaborative studies and new directions. Food Chem. Toxicol. 1992, 30:165-169.
21. Kobayashi S., Nagano H., Marubashi S., Hama N., Eguchi T.A., Takeda Y., Tanemura M., Doki Y., Mori M. Guaanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection. Transpl. Int. 2010, 23:390-396.
22. Krebs C.J., Larkins L.K., Price R., Tullis K.M., Miller R.D., Robins D.M. Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression. Genes Dev. 2003, 17:2664-2674.
23. Ku H.O., Jeong S.H., Kang H.G., Pyo H.M., Cho J.H., Son S.W., Ryu D.Y. Analysis of differential gene expression in auricular lymph nodes draining skin exposed to sensitizers and irritants. Toxicol. Lett. 2008, 177:1-9.
24. Ku N.O., Strnad P., Zhong B.H., Tao G.Z., Omary M.B. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology 2007, 46:1639-1649.
25. Li J., Hawkins I.C., Harvey C.D., Jennings J.L., Link A.J., Patton J.G. Regulation of alternative splicing by SRrp86 and its interacting proteins. Mol. Cell. Biol. 2003, 23:7437-7447.
26. McGarry H.F. The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicology 2007, 238:71-89.
27. McLean A.G., Hughes D., Welsh K.I., Gray D.W., Roake J., Fuggle S.V., Morris P.J., Dallman M.J. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997, 63:374-380.
28. Naschberger E., Bauer M., Stürzl M. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Adv. Enzyme Regul. 2005, 45:215-227.
29. Niwa M., Nagai K., Oike H., Kobori M. Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model. Biol. Pharm. Bull. 2009, 32:203-208.
30. Phillips I.R., Shephard E.A. Flavin-containing monooxygenases: mutations, disease and drug response. Trends Pharmacol. Sci. 2008, 29:294-301.
31. Quigley R.L. Application of the popliteal lymph node assay to evaluate an immunosuppression protocol. J. Surg. Res. 1994, 56:28-31.
32. Rathinam C., Lassmann H., Mengel M., Klein C. Transcription factor Gfi1 restricts B cell-mediated autoimmunity. J. Immunol. 2008, 181:6222-6229.
33. Rumberger B., Kreutz C., Nickel C., Klein M., Lagoutte S., Teschner S., Timmer J., Gerke P., Walz G., Donauer J. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro. Immunopharmacol. Immunotoxicol. 2009, 31:283-292.
34. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., Salvatierra O. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 2003, 349:125-138.
35. Sharma V.K., Bologa R.M., Li B., Xu G.P., Lagman M., Hiscock W., Mouradian J., Wang J., Serur D., Rao V.K., Suthanthiran M. Molecular executors of cell death - differential intrarenal expression of Fas ligand Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996, 62:1860-1866.
36. Spierings E., Wieles B., Goulmy E. Minor histocompatibility antigens - big in tumour therapy. Trends Immunol. 2004, 25:56-60.
37. Stepnik M., Rydzyński K., Arkusz J., Barańska M., Stańczyk M., Lewińska D. Testing the immunosuppressive effects of cyclophosphamide in the popliteal lymph node assay in the modification of graft-vs-host reaction (PLNA-GvHR) in the rat. Toxicol. Mech. Methods 2004, 14:367-373.
38. Stone M.R., O'Neill A., Lovering R.M., Strong J., Resneck W.G., Reed P.W., Toivola D.M., Ursitti J.A., Omary M.B., Bloch R.J. Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J. Cell Sci. 2007, 120:3999-4008.
39. Stopka P., Janotova K., Heyrovsky D. The advertisement role of major urinary proteins in mice. Physiol. Behav. 2007, 91:667-670.
40. Strehlau J., Pavlakis M., Lipman M., Shapiro M., Vasconcellos L., Harmon W., Strom T.B. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:695-700.
41. Suda A., Yamashita M., Tabei M., Taguchi K., Vohr H.W., Tsutsui N., Suzuki R., Kikuchi K., Sakaguchi K., Mochizuki K., Nakamura K. Local lymph node assay with non-radioisotope alternative endpoints. J. Toxicol. Sci. 2002, 27:205-218.
42. Takeyoshi M., Yamasaki K., Yakabe Y., Takatsuki M., Kimber I. Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2′-deoxyuridine (BrdU) incorporation. Toxicol. Lett. 2001, 119:203-208.
43. van den Berg F.A., Baken K.A., Vermeulen J.P., Gremmer E.R., van Steeg H., van Loveren H. Use of the local lymph node assay in assessment of immune function. Toxicology 2005, 211:107-114.
44. Yang Y., Chang B.H., Samson S.L., Li M.V., Chan L. The Krüppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res. 2009, 37:2529-2538.
45. Yi X., Kim K., Yuan W., Xu L., Kim H.S., Homeister J.W., Key N.S., Maeda N. Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury. J. Leukoc. Biol. 2009, 85:146-153.
46. Zheng X.X., Schachter A.D., Vasconcellos L., Strehlau J., Tian Y., Shapiro M., Harmon W., Strom T.B. Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation 1998, 65:1512-1515.
47. Zhu B., Symonds A.L., Martin J.E., Kioussis D., Wraith D.C., Li S., Wang P. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J. Exp. Med. 2008, 205:2295-2307.